FDA Adverse Event
Injury
Summary report: N
FLEXTEND II
MDR report key: 3211156
·
Received July 8, 2013
Report
- Report Number
- 2124215-2013-08029
- Event Type
- Injury
- Date Received
- July 8, 2013
- Date of Event
- May 2, 2013
- Report Date
- May 2, 2013
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT ATRIAL LEAD HAD INCREASE OUT OF RANGE PACING IMPEDANCES AND INCREASE PACING THRESHOLDS. A NEW RIGHT ATRIAL LEAD WAS IMPLANTED. THIS RIGHT ATRIAL LEAD WAS SURGICALLY ABANDONED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 310368 | FLEXTEND II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4096 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 70 YR | Hospitalization| L| R | 0175| P143| 4096| 0185| 5076| H230| 4542| 4543| 0181 |